Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07008027 · ClinicalTrials.gov registry record
Real World Asparaginase Therapy Toxicity
A clinical trial, sponsored by St. Jude Children's Research Hospital.
- Not yet
- Registry status
- 200
- Enrollment target
NCT07008027 is a clinical trial that has not yet begun recruiting, run by St. Jude Children's Research Hospital. The registered enrollment target is 200 participants.
The verdict
NCT07008027 has not yet begun recruiting, sponsored by St. Jude Children's Research Hospital.
- NOT YET RECRUITING
- Registry status
- 200 participants
- Enrollment target
Study Summary
This research study is being done to learn more about the short term and long term side effects of treatment with asparaginase drugs, which are commonly used in acute lymphoblastic leukemia (ALL) or acute lymphoblastic lymphoma (LLy) therapy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2026-07 |
| Est. Completion | 2031-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07008027
The ClinicalTrials.gov registry entry for NCT07008027 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT07008027 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07008027 about?
NCT07008027 is a clinical study titled "Real World Asparaginase Therapy Toxicity". This research study is being done to learn more about the short term and long term side effects of treatment with asparaginase drugs, which are commonly used in acute lymphoblastic leukemia (ALL) or acute lymphoblastic lymphoma (LLy) therapy.
What is the current status of trial NCT07008027?
This trial is currently not yet recruiting. The enrollment target is 200 participants. The study started on 2026-07. Estimated completion is 2031-07.
Who is sponsoring clinical trial NCT07008027?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.